Results 141 to 150 of about 5,245,251 (341)

Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2022
C. Bradbury, P. Lawler, S. Stanworth, B. McVerry, Z. McQuilten, A. Higgins, P. Mouncey, Farah Al-Beidh, K. Rowan, L. Berry, E. Lorenzi, R. Zarychanski, Y. Arabi, D. Annane, Abi Beane, Wilma van Bentum-Puijk, Zahra Bhimani, S. Bihari, M. Bonten, F. Brunkhorst, Adrian Buzgau, M. Buxton, M. Carrier, A. Cheng, Matthew E. Cove, M. Detry, L. Estcourt, M. Fitzgerald, T. Girard, E. Goligher, H. Goossens, R. Haniffa, T. Hills, David T. Huang, Christopher M. Horvat, Beverley Hunt, Nao Ichihara, F. Lamontagne, H. Leavis, K. Linstrum, E. Litton, J. Marshall, D. McAuley, A. McGlothlin, S. McGuinness, S. Middeldorp, S. Montgomery, S. Morpeth, S. Murthy, M. Neal, A. Nichol, R. Parke, Jane C. Parker, Luis Reyes, Hiroki Saito, Marlene S. Santos, Christina T. Saunders, A. Serpa-Neto, C. Seymour, M. Shankar-Hari, Vanessa Singh, T. Tolppa, A. Turgeon, Anne M Turner, F. L. van de Veerdonk, Cameron Green, R. J. Lewis, D. Angus, C. McArthur, S. Berry, L. Derde, S. Webb, A. Gordon   +72 more
semanticscholar   +1 more source

ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison.

Journal of the American College of Cardiology, 2018
Dual antiplatelet therapy (DAPT) is the cornerstone of pharmacological treatment aimed at preventing the atherothrombotic complications in patients with a variety of coronary artery disease (CAD) manifestations.
D. Capodanno, F. Alfonso, G. Levine, M. Valgimigli, D. Angiolillo   +4 more
semanticscholar   +1 more source

Drug‐coated balloons: From conventional designs to next‐generation innovations in vascular therapy

BMEMat, EarlyView.
This review traces the evolution of drug‐coated balloons (DCBs) from conventional designs to next‐generation platforms. We highlight innovations in balloon engineering, coating technologies, and therapeutic agents that enhance localized drug delivery while addressing challenges in efficiency, safety, and biocompatibility for vascular and emerging non ...
Lu Zhang, Jiawei Cui, Jin Wang, Manfred F. Maitz, Rifang Luo, Yunbing Wang   +5 more
wiley   +1 more source

Antiplatelet Therapy [PDF]

Circulation, 2003
Ian Conde-Pozzi, Neal S. Kleiman
  +5 more sources

Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy: A Systematic Review and Meta‐analysis of 19 Studies

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundThe safety and long‐term outcome of systemic thrombolysis in patients receiving antiplatelet medications remain subjects of great clinical significance.
Shengyuan Luo, Mei Zhuang, Wutao Zeng, Jun Tao   +3 more
doaj   +1 more source

Predicting Bleeding and Thrombosis Complications in Patients with Continuous Flow Left Ventricular Assist Devices [PDF]

, 2020
Background: Left ventricular assist device (LVAD) therapy has been proven to relieve heart failure symptoms and improve survival, but is not devoid of bleeding and/or thrombotic complications.
Cook, Aaron, Kuan, William, McCann, Justin McCann, Parli, Sara, Schadler, Aric, Sieg, Adam, Zacholski, Kyle   +6 more
core   +1 more source

The Prognostic Impact of Multiple Adverse Events on Long‐Term Mortality Following Acute Myocardial Infarction

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Adverse events after acute myocardial infarction (AMI) are individually associated with poor outcomes, but the prognostic impact of the overlap of different event types occurring sequentially within the same patient remains uncertain.
Kyung Hoon Roh, Yong Hee Kim, Eun Ho Choo, Kwan Yong Lee, Ik Jun Choi, Jong‐Min Lee, Ki‐Dong Yoo, Mahn‐Won Park, Chul Soo Park, Hee‐Yeol Kim, Min Chul Kim, Youngkeun Ahn, Kiyuk Chang   +12 more
wiley   +1 more source

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

British medical journal, 2002
C. Baigent, Catherine Sudlow, R. Collins, R. Peto, Antithromboci Trialists Collaborat   +4 more
semanticscholar   +2 more sources

Dynamics of hemostasis system parameters in assessing the risk of complications in the patients with acute myocardial infarction receiving antiplatelet therapy

Трансплантология (Москва)
Background. Current treatment of patients with myocardial infarction is based on the strategy of early invasive coronary intervention in combination with dual antiplatelet therapy - with acetylsalicylic acid and a P2Y12 blocker of platelet adenosine ...
T. R. Gvindzhiliya, I. M. Kuzmina, E. V. Klychnikova, E. V. Tazina, A. A. Kochetova, N. A. Muradyan, A. S. Bogdanova   +6 more
doaj   +1 more source

Outcomes of Left Atrial Appendage Occlusion in Heart Failure With Reduced Ejection Fraction

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from major trials of left atrial appendage occlusion (LAAO). Aim The objective of this study was to describe this population and evaluate outcomes after LAAO in patients with and without HFrEF.
Aamer Ubaid, Arindam Bagga, Kevin Kennedy, John T. Saxon, Chetan P. Huded   +4 more
wiley   +1 more source